Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
NovelMed Therapeutics Inc is excited to announce the commencement of its Phase II clinical trial for the treatment of newly diagnosed Paroxysmal Nocturnal Hemoglobinuria patients using their groundbreaking antiBb antibody NM
Aquinnah Pharmaceuticals has revealed promising preclinical research findings for a novel therapy designed to slow or halt the progression of Alzheimers disease and related neurodegenerative disorders
Oncoinvent AS a clinicalstage company specializing in alpha emitter therapy for various solid cancers has received clearance from the US Food and Drug Administration for its Investigational New Drug application
RLS Radiopharmacies the sole radiopharmacy network accredited by the Joint Commission in the United States has unveiled plans to expand its business operations by offering radiopharmaceutical contract development
ERS Genomics Limited is pleased to announce a novel licensing agreement with the CHUM Research Centre This nonexclusive agreement grants CRCHUM research rights to ERSs CRISPRCas patent portfolio
EnginZyme AB is a pioneering deeptech company specializing in acellular biomanufacturing technology that harnesses the potential of enzymes to create sustainable products and processes across various industries
Lupus Therapeutics the clinical research affiliate of the Lupus Research Alliance has established a partnership with AbbVie Inc to advance the Phase clinical program of upadacitinib for individuals living with systemic lupus erythematosus
Inimmune Corporation a clinicalstage biotechnology company focused on developing innovative immunotherapeutics has announced a research collaboration with Boston Childrens Hospital to create novel small molecule vaccine adjuvants
TC BioPharm PLC trading under the symbol TCBP on NASDAQ is a biotechnology company in the clinical development stage focusing on the creation of allogeneic gammadelta T cell therapies for cancer treatment
Skyhawk Therapeutics Inc has recently received approval from the Australian Human Research Ethic Committee and Australian regulators for a clinical trial of their small molecule candidate SKY aimed at addressing Huntingtons disease
